Hawaii Cancer Care — Honolulu, Hawaii

Hawaii Cancer Care is a clinical research site located in Honolulu, Hawaii, United States 96813.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Hawaii Cancer Care has participated in 12 clinical trials with 5 currently active.

Therapeutic areas: Non-small Cell Lung Cancer, NMIBC, Advanced or Metastatic Solid Tumors.

Sponsors: EMD Serono Research & Development Institute, Inc., ImmunityBio, Inc., Incyte Corporation.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Hawaii Cancer Care?

Hawaii Cancer Care has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Hawaii Cancer Care conducted?

Hawaii Cancer Care has 12 clinical trials on record, with 5 currently active. Their work covers Non-small Cell Lung Cancer, NMIBC, Advanced or Metastatic Solid Tumors.

Is Hawaii Cancer Care accredited by Crixeo Health?

Yes — Hawaii Cancer Care holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Hawaii Cancer Care?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.